Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers.
Pukrittayakamee S. et al, (2024), eLife, 12
An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria-authors' response.
Saralamba S. et al, (2024), J Antimicrob Chemother
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Luvira V. et al, (2024), BMC Infectious Diseases, 24
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
Schilling WHK. et al, (2024), The Lancet Infectious Diseases, 24, 36 - 45
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
Jittamala P. et al, (2023), The Journal of Infectious Diseases, 228, 1318 - 1325
Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria.
Watson JA. et al, (2023), PLoS Med, 20
A systematic review of neglected tropical diseases (NTDs) in Myanmar.
Swe MMM. et al, (2023), PLoS neglected tropical diseases, 17
Successful elimination of falciparum malaria following the introduction of community-based health workers in Eastern Myanmar: A retrospective analysis.
Zaw AS. et al, (2023), PLoS medicine, 20
Prevalence and Risk Factors of Neonatal Hyperbilirubinemia in a Semi-Rural Area of the Democratic Republic of Congo: A Cohort Study
Fanello C. et al, (2023), The American Journal of Tropical Medicine and Hygiene, 109, 965 - 974
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
Mehdipour P. et al, (2023), Malaria journal, 22
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
Mukaka M. et al, (2023), eBioMedicine, 96, 104805 - 104805
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
Taylor WRJ. et al, (2023), PLOS Neglected Tropical Diseases, 17, e0011522 - e0011522
Evidence based optimal dosing of intravenous artesunate in children with severe falciparum malaria
Haghiri A. et al, (2023), Clinical Pharmacology & Therapeutics
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
Thriemer K. et al, (2023), BMC Medical Research Methodology, 23
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
Commons RJ. et al, (2023), The Lancet Infectious Diseases
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
Rajasekhar M. et al, (2023), The Lancet Infectious Diseases
Severe Falciparum and Vivax Malaria on the Thailand-Myanmar Border: A Review of 1503 Cases.
Chu CS. et al, (2023), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 77, 721 - 728